These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 354326)

  • 1. A retrospective evaluation of pipamperone (Dipiperon) in the treatment of behavioural deviations in severely mentally handicapped.
    Haegeman J; Duyck F
    Acta Psychiatr Belg; 1978; 78(2):392-8. PubMed ID: 354326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation.
    Deberdt R
    Acta Psychiatr Belg; 1976; 76(1):157-66. PubMed ID: 970185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating severe maladjustment with pipamperone (Dipiperon).
    Noordhuizen GJ
    Acta Psychiatr Belg; 1977; 77(6):754-60. PubMed ID: 610354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Character neuroses and behavioural disorders in children: their treatment with pipamperone (Dipiperon). A clinical study.
    Van Renynghe de Voxvrie G; De Bie M
    Acta Psychiatr Belg; 1976; 76(4):688-95. PubMed ID: 1020694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pipamperone (Dipiperon), a useful sedative neuroleptic drug in troublesome chronic psychotic patients.
    Squelart P; Saravia J
    Acta Psychiatr Belg; 1977; 77(2):284-93. PubMed ID: 906888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pipamperone (Dipiperon, R3345) in troublesome mental retardates: a double-blind placebo controlled cross-over study with long-term follow-up.
    van Hemert JC
    Acta Psychiatr Scand; 1975 Oct; 52(4):237-45. PubMed ID: 1103575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep disorders in patients with severe mental depression: double-blind placebo-controlled evaluation of the value of pipamperone (Dipiperon).
    Ansoms C; Backer-Dierick GD; Vereecken JL
    Acta Psychiatr Scand; 1977 Feb; 55(2):116-22. PubMed ID: 320830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dipiperon treatment in a psychiatric out-patient clinic for children and youths].
    Müller-Küppers M
    Acta Paedopsychiatr; 1971; 38(2):40-6. PubMed ID: 4942603
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic trials and EEG investigations with SCH-12,679 in behaviorally disturbed adolescents.
    Itil TM; Stock MJ; Duffy AD; Esquenazi A; Saleuty B; Han TH
    Curr Ther Res Clin Exp; 1972 Mar; 14(3):136-50. PubMed ID: 4622893
    [No Abstract]   [Full Text] [Related]  

  • 10. Retrospective study of lithium use for institutionalized mentally retarded individuals with behavior disorders.
    Langee HR
    Am J Ment Retard; 1990 Jan; 94(4):448-52. PubMed ID: 2105098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trial with R-3345].
    Bastos O; Carvalho RG
    J Bras Psiquiatr; 1970; 19(3):251-6. PubMed ID: 4949175
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine.
    Friedman DL; Kastner T; Plummer AT; Ruiz MQ; Henning D
    Am J Ment Retard; 1992 Mar; 96(5):541-6. PubMed ID: 1562312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pimozide in the treatment of some "social maladjustments" in "personality disorders".
    Collard J
    Acta Psychiatr Belg; 1979; 79(6):686-703. PubMed ID: 554447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic treatment of oligophrenic patients. A double-blind clinical multicentre trial of cis(Z)-clopenthixol and haloperidol.
    Karsten D; Kivimäki T; Linna SL; Pollari L; Turunen S
    Acta Psychiatr Scand Suppl; 1981; 294():39-45. PubMed ID: 7041518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pipamperone and the treatment of impulsive aggressive behaviour].
    Klaassen AA
    Tijdschr Psychiatr; 2008; 50(3):179-83. PubMed ID: 18324605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of methylperon (Eunerpan) on aggressive and auto-aggressive behaviour in mentally retarded patients--a double blind study (author's transl)].
    Hacke W; Büssing A; Jungen K
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):86-96. PubMed ID: 25446
    [No Abstract]   [Full Text] [Related]  

  • 17. Lithium treatment of behavioural disturbances in patients with defective intellect.
    Müllerová S; Novotná J; Rehan V; Skula E
    Act Nerv Super (Praha); 1974 Aug; 16(3):196. PubMed ID: 4421599
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
    Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
    Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.